| Dutch tariff for the five-level version of EQ-5D MM Versteegh, KM Vermeulen, SMAA Evers, GA De Wit, R Prenger, ... Value in health 19 (4), 343-352, 2016 | 528 | 2016 |
| Age-specific incidence and prevalence of keratoconus: a nationwide registration study DA Godefrooij, GA De Wit, CS Uiterwaal, SM Imhof, RPL Wisse American journal of ophthalmology 175, 169-172, 2017 | 341 | 2017 |
| Lifetime medical costs of obesity: prevention no cure for increasing health expenditure PHM van Baal, JJ Polder, GA de Wit, RT Hoogenveen, TL Feenstra, ... PLoS medicine 5 (2), e29, 2008 | 323 | 2008 |
| Sensitivity and perspective in the valuation of health status: whose values count? GA De Wit, JJV Busschbach, FT De Charro Health economics 9 (2), 109-126, 2000 | 264 | 2000 |
| Economic evaluation of end stage renal disease treatment GA De Wit, PG Ramsteijn, FT de Charro Health policy 44 (3), 215-232, 1998 | 238 | 1998 |
| Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective IK Veldhuijzen, M Toy, SJM Hahné, GA De Wit, SW Schalm, A Robert, ... Gastroenterology 138 (2), 522-530, 2010 | 170 | 2010 |
| Effectiveness and Efficiency of Controlling Campylobacter on Broiler Chicken Meat AH Havelaar, MJJ Mangen, AA De Koeijer, MJ Bogaardt, EG Evers, ... Risk Analysis: An International Journal 27 (4), 831-844, 2007 | 167 | 2007 |
| The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination H de Melker, G Berbers, S Hahné, H Rümke, S van den Hof, A de Wit, ... Vaccine 24 (18), 3946-3952, 2006 | 167 | 2006 |
| Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment RW Sprengers, M Teraa, FL Moll, GA De Wit, Y Van Der Graaf, ... Journal of vascular surgery 52 (4), 843-849. e1, 2010 | 144 | 2010 |
| Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis JP Greving, FLJ Visseren, GA De Wit, A Algra Bmj 342, 2011 | 140 | 2011 |
| The effect of including an opt-out option in discrete choice experiments J Veldwijk, MS Lambooij, EW de Bekker-Grob, HA Smit, GA de Wit PloS one 9 (11), e111805, 2014 | 129 | 2014 |
| Economic evaluation of vaccination programmes P Beutels, WJ Edmunds, F Antoñanzas, GA De Wit, D Evans, R Feilden, ... Pharmacoeconomics 20 (1), 1-7, 2002 | 120 | 2002 |
| Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation IVF van den Broek, JEAM van Bergen, EEHG Brouwers, JSA Fennema, ... Bmj 345, 2012 | 119 | 2012 |
| Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands MJJ Mangen, MH Rozenbaum, SM Huijts, CH van Werkhoven, ... European Respiratory Journal 46 (5), 1407-1416, 2015 | 116 | 2015 |
| Rapid screening of methicillin‐resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects MWM Wassenberg, JAJW Kluytmans, ATA Box, RW Bosboom, ... Clinical microbiology and infection 16 (12), 1754-1761, 2010 | 112 | 2010 |
| Costs of gastroenteritis in The Netherlands WE Van Den Brandhof, GA De Wit, MAS De Wit, Y Van Duynhoven Epidemiology & Infection 132 (2), 211-221, 2004 | 104 | 2004 |
| Preventive exercises reduced injury-related costs among adult male amateur soccer players: a cluster-randomised trial MR Krist, AMC van Beijsterveldt, FJG Backx, GA de Wit Journal of physiotherapy 59 (1), 15-23, 2013 | 99 | 2013 |
| A comparison of quality of life of patients on automated and continuous ambulatory peritoneal dialysis GA De Wit, MP Merkus, RT Krediet, FT De Charro Peritoneal Dialysis International 21 (3), 306-312, 2001 | 94 | 2001 |
| Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157 AH Havelaar, Y Van Duynhoven, MJ Nauta, M Bouwknegt, AE Heuvelink, ... Epidemiology & Infection 132 (3), 467-484, 2004 | 92 | 2004 |
| The impact of a healthy lifestyle on Disability-Adjusted Life Years: a prospective cohort study AM May, EA Struijk, HP Fransen, NC Onland-Moret, GA de Wit, J Boer, ... BMC medicine 13 (1), 1-9, 2015 | 90 | 2015 |
